ARTICLE | Company News
Incyte, Novartis deal
February 2, 2015 8:00 AM UTC
Incyte will receive a $25 million milestone payment from Novartis under a 2009 deal granting the pharma exclusive, ex-U.S. rights to Jakavi ruxolitinib. The milestone was triggered by EMA’s CHMP reco...